San Diego, CA -- (SBWire) -- 07/27/2015 --The Shareholders Foundation announces that an investigation for investors in Vital Therapies Inc (NASDAQ:VTL) shares was launched concerning potential violations of securities laws Vital Therapies Inc and certain of its directors and officers in connection certain financial statements.
Investors who purchased shares of Vital Therapies Inc (NASDAQ:VTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Vital Therapies Inc (NASDAQ:VTL) concerning whether a series of statements by Vital Therapies Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On July 14, 2015, a report was published alleging that Vital Therapies Inc's representations regarding the 90 day overall survival rate for those treated with Vital Therapies' Extracorporeal Liver Assist Device ("ELAD") were highly misleading, as they allegedly included survival data from a patient who received a liver transplant, while no equivalent patient in the control group had received a transplant. The report alleged that this fact was not disclosed in any of the Company's prior disclosures concerning the Phase 2 VTI-206 study of ELAD. Shares of Vital Therapies Inc (NASDAQ:VTL) declined July 22, 2015, to as low as $16.12 per share.
Those who purchased shares of Vital Therapies Inc (NASDAQ:VTL) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Vital Therapies Inc (NASDAQ:VTL) Shareholder Notice: Investigation over Potential Securities Laws Violations
An investigation for investors in Vital Therapies Inc (NASDAQ:VTL shares over potential securities laws violations by Vital Therapies Inc was announced and NASDAQ:VTL stockholders should contact the Shareholders Foundation.